Abstract:Background: There is no consensus on whether intravenous rehydration must be added after preoperative phenoxybenzamine (PXB) administration for pheochromocytoma. The aim of this study is to investigate whether abandonment of intravenous volume expansion after PXB administration is associated with intraoperative hemodynamic instability. Methods: 83 Patients with pheochromocytoma received surgical treatment in the Department of Urology, Handan First Hospital, between October 2014 and July 2022. All patients were subclassified into either the hemodynamic stability group (HS group) or the hemodynamic instability group (HU group) according to whether intraoperative hemodynamic instability occurred, with 51 cases in HS group and 32 cases in HU group. Differences in data between the two groups were examined, and the risk factors for intraoperative hemodynamic instability were analyzed using logistic regression. Results: The results of the analysis showed no statistically significant differences in age, sex, location of the tumor, surgical method, body mass index (BMI) ≥ 24 kg/m 2 , blood and urine catecholamine test results, preoperative oral PXB followed by combined intravenous volume expansion, proportion of patients with hypertension or diabetes mellitus or coronary heart disease between the two groups (P>0.05). The size of the tumor in the HS group was smaller than that in the HU group (5.3 ± 1.9 cm vs 6.2 ± 2.4 cm P=0.010). Multivariate analyses demonstrated that abandonment of intravenous volume expansion after preoperative receipt of α-blockers in patients with adrenal pheochromocytoma was not an independent risk factor for intraoperative hemodynamic instability. Only the tumor size (P=0.025) was an independent risk factor for intraoperative hemodynamic instability. Conclusion: The purpose of general preoperative intravenous fluid expansion is to prevent hypotension after the tumor has been resected. In the current study, we indicated that preoperative management of pheochromocytomas using the α-blocker PXB in combination with intravenous volume expansion does not further reduce the risk of intraoperative hemodynamic instability or postoperative complications compared with oral PXB alone. Therefore, our study supports preoperative management of pheochromocytoma with a single α-blocker, PXB, as sufficient.

CONTROLLED-RELEASE TABLETS OF DOXAZOSIN MESYLATE AND PHENOXYBENZAMINE IN PREOPERATIVE PREPARATION AND BLOOD PRESSURE CONTROL FOR PHEOCHROMOCYTOMA PATIENTS

Controlled-release tablets of Doxazosin Mesylate and Phenoxybenzamine in pre-operative preparation and blood pressure control for pheochromocytoma patients

Selective α 1 -adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma

Application of doxazosin mesylate controlled release tablets in preoperative volume dilation preparation of patients with pheochromocytomas

Compare the effects of doxazosin mosylate and phenoxybenzamine in preoperative preparation of pheochromocytoma

Comparison of effects of doxazosin and phenoxybenzamine on intraoperative hemodynamics in patients with normotensive pheochromocytoma

Clinical Analysis of Preoperative Preparation for Pheochromocytoma

Perioperative management for pheochromocytoma

The preoperative control of high blood pressure and acute hypervolemic hemodilution in operation of pheochromocytoma

Preoperative Alpha Blockade for Normotensive Pheochromocytoma: is It Necessary?

The Duration Of Preoperative Administration Of Single Alpha-Receptor Blocker Phenoxybenzamine Before Adrenalectomy For Pheochromocytoma: 18 Years Of Clinical Experience From Nationwide High-Volume Center

The Duration of Preoperative Administration of Single <i>α</i>-Receptor Blocker Phenoxybenzamine before Adrenalectomy for Pheochromocytoma: 18 Years of Clinical Experience from Nationwide High-Volume Center

Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases

The Use of Doxazosin Before Adrenalectomy for Pheochromocytoma: is the Duration Related to Intraoperative Hemodynamics and Postoperative Complications?

Improvement in the Diagnosis and Treatment of Pheochromocytoma Perioperatively

[Perioperative Hemodynamics in Pheochromocytoma Secreting Different Types of Catecholamine].

The Characteristics of Peroperative Blood Pressure and Heart Rate in Patients with Normotensive Incidental Pheochromocytomas

Abandonment of intravenous volume expansion after preoperative receipt of α-blockers in patients with adrenal pheochromocytoma was not an independent risk factor for intraoperative hemodynamic instability

Anesthetic management for surgical treatment of pheochromocytoma

Clinical features of pheochromocytoma and perioperative anesthetic management

Preoperative selective versus non-selective α-blockade in PPGL patients undergoing adrenalectomy.